Assistant Professor, Internal Medicine, Mayo Medical School
Hematology
Dr. John K. Camoriano, MD
|
|
Give Review
John Camoriano works in the field of Hematology. He received awards:"America's Top Doctors", "Top Doctors:Arizona State" and "America's Top Doctors for Cancer". John K. Camoriano, MD is a published doctor. He has 37 publications published. The most current publication "Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura." He is registered with Medicare and accepts Medicare payments.
Publications
- BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in Myeloid malignancies.
- A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal Carcinoma.
- Gemcitabine and Docetaxel for Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial.
- Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial.
- Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Stu...
- Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with Myeloid metaplasia.
- A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
- The Office of Advanced Technology: providing focus on the piloting and implementation of new technology.
- Phase 2 trial of imatinib mesylate in myelofibrosis with Myeloid metaplasia.
- Managing technology in a physician-led organization.
- FIP1L1-PDGFRA in eosinophilic Disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.
- The burden of fatigue and quality of life in myeloproliferative Disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
- International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with Myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatm...
- Fulvestrant in women with advanced breast Cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
- Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic Syndromes (MDS): results of a large internet-based survey.
- A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia.
- International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-...
- Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom Macroglobulinemia.
- The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
- Malignant fibrous histiocytoma of the Lung. Report of four cases and review of the literature.
- Diagnosis of Castleman's Disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
- Thoracoscopic excision of a peripheral corticotropin-secreting pulmonary carcinoid tumor.
- Transdermal scopolamine psychosis.
- Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy.
- Acquired divergent strabismus: presumed metastatic gastric Carcinoma to the medial rectus muscle.
- Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic Syndrome.
- Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast Cancer.
- Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical Analy...
- Phase II study of paclitaxel and cisplatin for advanced urothelial Cancer.
- Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of Cancer anorexia/cachexia.
- Long-term results of laparoscopic splenectomy for Immune thrombocytopenic purpura.
- A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin''s Lymphoma.
- Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
- A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promisin...
- A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic Breast carcinoma.
- Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy.
Schools
University Of Nebraska College Of Medicine
University Of Oklahoma
Mayo Grad School Med
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Arizona State
- America's Top Doctors for Cancer
Education
-
Mayo School of Graduate Medical Education -
University of Oklahoma Health Sciences Center
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1396723425 | |
| NPPES Provider LastName | CAMORIANO | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 852595404 | |
| NPPES Provider State | AZ | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 494.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396723425 |
| Last Name Of The Provider | CAMORIANO |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Tom R. Fitch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Slack, MD |
|
|
Dr. Katalin Kelemen, MD |
|
|
Dr. Alexander K. Stewart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James O. Newell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan Robetorye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen S. Anderson, MD |
|
|
Dr. Sharon D. Gburek, MD
This Doctor is OpenDoctor Recommended.
|